Activery The amorphization specialist
Activery believes that amorphous drugs provide new and innovative routes to final dosage forms with differentiated pharmacokinetics
| The global OTC pharmaceuticals market grew by 3.9% in 2008 to reach a value of $104.2 billion |
 |
 |
 |
|
How is the OTC pharmaceuticals market defined?
The OTC pharmaceuticals market values the total sales of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirin, other analgesics), and other OTC healthcare products including; medicated skin products (anti-bacterials, acne treatments, antifungals, other medicated skin products, disinfectants), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, other tape or bandage, liquid bandages), first aid kits and other OTC healthcare products (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, motion sickness). The market values are at retail selling price (RSP) and include any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2007 annual average exchange rates. For the purpose of this report the Americas comprise Brazil, Canada, Mexico and the US. Europe comprises Belgium, the Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden and the UK. Asia-Pacific comprises Australia, China, Japan, India, Singapore, South Korea and Taiwan. The global figure comprises the Americas, Asia-Pacific and Europe. Market Value The global OTC pharmaceuticals market grew by 3.9% in 2008 to reach a value of $104.2 billion. The compound annual growth rate of the market in the period 2004-2008 was 4%. Product Market Segmentation Sales of traditional medicines account for 20.3% of the global OTC pharmaceutical market's overall value. In comparison, sales of cough and cold preparations account for 15.5% of the market's value. Geographical Market Segmentation The Asia-Pacific accounts for 38.2% of the global OTC pharmaceutical market's value. Europe accounts for a 29.9% of the global market's value, while the US market holds a further 24.5%. Distribution Pharmacies and drug stores distribute 57.8% of the value within the global OTC pharmaceutical market. In comparison, supermarkets and hypermarkets distribute 14.3% of the market's value. Global OTC Pharmaceuticals Market Share: % Share, by Value, 2008(e) "Pfizer is a leading company in global OTC pharmaceuticals market with 7.2% of the market's value. GlaxoSmithkline Plc holds further 5.2% of the global OTC pharmaceuticals market's share..."
|
Pharma Notes
- New study on Inhaled Drug Delivery Market
- Particles that deliver larger and more effective doses of drugs to cancers
- The global protein therapeutics market will be worth $77bn by 2011 with biogenerics playing an increasingly important rol
- A federal jury in Texas Monday upheld the patent on Johnson & Johnson's arthritis treatment Remicade and ordered Abbott Laboratories to pay its rival $1.67 billion for infringing on the patent
- Transdermal delivery represents an attractive alternative to oral delivery of drugs and is poised to provide an alternative to hypodermic injection tool
Differentiated Generics
- Teva may lose patent challenge
- Labopharm receives notice of ANDA submission with paragraph IV certification for generic of Ryzolt
- Depomed (DEPO) Receives Paragraph IV Notice from Lupin Limited Over Patent Filing for Generic Glumetza Tablets
- The rate and number of successful Paragraph IV challenges is reducing the average effective patent life for innovator drugs
- Teva Sues Mylan Over Multiple Sclerosis Drug COPAXONE
Nanoparticles world
- Nanoparticle created to attack cardiovascular plaque
- Nanoparticle lung threat blocked
- Newly-developed nanoparticle to build therapies for treating individuals with cardiovascular disease.
- Nanoparticle Processing in the Solid State Dramatically Increases the Cell Membrane Permeation of a Cholesterol-Lowering Drug, Probucol
- Erectile dysfunction could be treated by a nanoparticle formulation applied directly to the penis